Investor Clough Capital Partners L P
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Clough Capital Partners L P . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2022-02-14 13G/A CMPI / Checkmate Pharmaceuticals Inc 1,552,326 1,137,764
2021-05-24 13G/A CMPI / Checkmate Pharmaceuticals Inc 1,351,218 1,552,326
2021-02-12 13G/A CMPI / Checkmate Pharmaceuticals Inc 1,332,397 1,351,218
2020-11-10 13G CMPI / Checkmate Pharmaceuticals Inc 1,332,397
2020-02-24 13G CORV / Correvio Pharma Corp. (Canada) 2,111,224 0
2019-02-14 13G CORV / Correvio Pharma Corp. (Canada) 2,111,224
2018-04-27 13G/A CRME / Cardiome Pharma Corp. 2,441,863 2,058,763
2018-04-27 13G/A CVNA / Carvana Co. 1,076,050 1,072,050
2018-02-13 13G CVNA / Carvana Co. 1,076,050
2018-02-13 13G/A CRME / Cardiome Pharma Corp. 2,044,653 2,441,863
2016-03-22 13G/A CRME / Cardiome Pharma Corp. 1,734,083 2,044,653
2016-01-12 13G TVTY / Tivity Health Inc 1,868,889 1,850,289
2016-01-12 13G KURA / Kura Oncology, Inc. 1,087,233 1,076,333
2016-01-12 13G/A VCYT / Veracyte, Inc. 1,439,036 1,049,054
2015-10-20 13G/A CRME / Cardiome Pharma Corp. 1,561,483 1,734,083
2015-08-14 13G CRME / Cardiome Pharma Corp. 1,561,483
2015-06-01 13G VCYT / Veracyte, Inc. 1,439,036
2013-02-11 13G/A SUNS / Sunrise Realty Trust, Inc. 325,093
2012-02-08 13G/A SUNS / Sunrise Realty Trust, Inc. 634,296